| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $1,077,090 | 3 | 100 |
| de Urioste George | director | 0 | $0 | 2 | $182,090 | $-182,090 |
| STROME MARK E | 10 percent owner | 0 | $0 | 1 | $895,000 | $-895,000 |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Over the last 12 months, insiders at HeartBeam, Inc. have bought $0 and sold $1.08M worth of HeartBeam, Inc. stock.
On average, over the past 5 years, insiders at HeartBeam, Inc. have bought $90,353 and sold $399,329 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 29,412 shares for transaction amount of $50,000 was made by Ferrari Richard (director) on 2025‑02‑14.
| 2025-12-18 | Sale | de Urioste George | director | 33,185 0.1008% | $2.83 | $93,914 | -27.12% | |
| 2025-12-17 | Sale | STROME MARK E | 10 percent owner | 250,000 0.8482% | $3.58 | $895,000 | -31.51% | |
| 2025-12-17 | Sale | de Urioste George | director | 23,961 0.0836% | $3.68 | $88,176 | -31.51% | |
| 2025-02-14 | Ferrari Richard | director | 29,412 0.086% | $1.70 | $50,000 | -23.00% | ||
| 2025-02-14 | Cruickshank Tim | CFO | 17,647 0.0516% | $1.70 | $30,000 | -23.00% | ||
| 2024-09-06 | Sale | de Urioste George | director | 1,674 0.0048% | $2.34 | $3,917 | -12.55% | |
| 2024-08-30 | Sale | de Urioste George | director | 5,500 0.0156% | $2.31 | $12,705 | -13.62% | |
| 2024-08-27 | Sale | de Urioste George | director | 2,194 0.0061% | $2.26 | $4,958 | -9.11% | |
| 2024-08-26 | Sale | de Urioste George | director | 300 0.0009% | $2.38 | $714 | -9.69% | |
| 2024-08-23 | Sale | de Urioste George | director | 2,500 0.007% | $2.30 | $5,750 | -11.49% | |
| 2023-09-29 | Sale | de Urioste George | director | 5,500 0.0139% | $2.06 | $11,330 | -3.26% | |
| 2023-09-28 | Sale | de Urioste George | director | 8,000 0.02% | $2.04 | $16,320 | +2.45% | |
| 2023-09-27 | Sale | de Urioste George | director | 1,834 0.0047% | $2.11 | $3,870 | -0.48% | |
| 2023-09-26 | Sale | de Urioste George | director | 5,000 0.0128% | $2.09 | $10,450 | -1.89% | |
| 2023-09-22 | Sale | de Urioste George | director | 2,393 0.0065% | $2.21 | $5,289 | -3.70% | |
| 2023-09-21 | Sale | de Urioste George | director | 100 0.0003% | $2.41 | $241 | -7.93% | |
| 2023-09-20 | Sale | de Urioste George | director | 883 0.0027% | $2.46 | $2,172 | -11.81% | |
| 2023-09-18 | Sale | de Urioste George | director | 5,000 0.0151% | $2.46 | $12,300 | -16.73% | |
| 2023-09-15 | Sale | de Urioste George | director | 4,269 0.0127% | $2.43 | $10,374 | -15.04% | |
| 2023-09-14 | Sale | de Urioste George | director | 5,000 0.0133% | $2.17 | $10,850 | -15.04% |
| STROME MARK E | 10 percent owner | 2900000 8.4196% | $4.06M | 0 | 1 | |
| de Urioste George | director | 0 0% | $0 | 0 | 18 | |
| Guidant Investment CORP | 10 percent owner | 787873 2.2874% | $1.1M | 0 | 1 | |
| Ferrari Richard | director | 179136 0.5201% | $250,790.40 | 1 | 0 | |
| Capper Joseph H | President & CEO | 178355 0.5178% | $249,697.00 | 12 | 20 | |
| GORMAN KIRK E | director | 173315 0.5032% | $242,641.00 | 4 | 6 | |
| PRYSTOWSKY ERIC N | director | 125706 0.365% | $175,988.40 | 1 | 5 | |
| BROUNSTEIN RICHARD D | Chief Financial Officer | 102075 0.2964% | $142,905.00 | 2 | 0 | <0.0001% |
| THURMAN RANDY H | Chairman, President & CEO | 62536 0.1816% | $87,550.40 | 1 | 0 | |
| Broadway Fred | President BioTel Heart | 24880 0.0722% | $34,832.00 | 0 | 20 | |
| Cruickshank Tim | CFO | 17647 0.0512% | $24,705.80 | 1 | 0 | |
| Ortigas-Wedekind Marga | director | 16824 0.0488% | $23,553.60 | 1 | 0 | <0.0001% |
| GALVAN MARTIN P | Chief Financial Officer | 11019 0.032% | $15,426.60 | 2 | 0 | |
| MIDDLETON FRED A | director | 8550 0.0248% | $11,970.00 | 0 | 2 | |
| Ferola Peter | SVP & General Counsel | 8507 0.0247% | $11,909.80 | 0 | 19 | |
| Sanderling Venture Partners IV, L.P. | 10 percent owner | 2370 0.0069% | $3,318.00 | 0 | 1 |
$1,197,867 | 27 | 63.73% | $603.35M | |
$171,033,572 | 24 | 220.69% | $2.63B | |
$1,129,324 | 21 | 20.33% | $102.18M | |
$10,866 | 12 | -23.14% | $20.13M | |
$2,429,291 | 8 | 27.89% | $295.53M | |
HeartBeam, Inc. (BEAT) | $100,706 | 3 | -58.80% | $48.22M |
$258,661,156 | 2 | 42.09% | $6.94B | |
$275,000 | 1 | -4.39% | $4.35M |
| Increased Positions | 19 | +38% | 1M | +40.26% |
| Decreased Positions | 19 | -38% | 552,339 | -15.33% |
| New Positions | 10 | New | 144,034 | New |
| Sold Out Positions | 11 | Sold Out | 448,018 | Sold Out |
| Total Postitions | 50 | 0% | 5M | +24.93% |
| Vanguard Group Inc | $2,718.00 | 3.29% | 1.12M | 0 | 0% | 2025-09-30 |
| Smith Salley Wealth Management | $893.00 | 1.08% | 367,647 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $713.00 | 0.86% | 293,598 | +38,732 | +15.2% | 2025-09-30 |
| Ubs Group Ag | $468.00 | 0.57% | 192,553 | -6,714 | -3.37% | 2025-09-30 |
| Kestra Private Wealth Services, Llc | $428.00 | 0.52% | 175,989 | +33,344 | +23.38% | 2025-09-30 |
| Ritholtz Wealth Management | $338.00 | 0.41% | 139,182 | 0 | 0% | 2025-09-30 |
| O'shaughnessy Asset Management, Llc | $338.00 | 0.41% | 139,182 | 0 | 0% | 2025-09-30 |
| Stifel Financial Corp | $243.00 | 0.29% | 100,000 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $219.00 | 0.27% | 90,044 | +1,836 | +2.08% | 2025-09-30 |
| Raymond James Financial Inc | $214.00 | 0.26% | 88,050 | +59,872 | +212.48% | 2025-09-30 |